Murphy & Mullick Capital Management Corp
Position in ILMN — Illumina, Inc.
CIK 2047271
SMITHTOWN, NY
Position in ILMN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,572
+$6,151 QoQ
Shares Held
117
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#785
of 932 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Murphy & Mullick Capital Management Corp holds $450,447 across 10 Diagnostics & Research names. ILMN ranks #5 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
363 | $181,993 | |
| 2 | DHR |
Danaher Corp /De/
|
761 | $144,955 | |
| 3 | WAT |
Waters Corp /De/
|
126 | $47,255 | |
| 4 | RVTY |
Revvity, Inc.
|
203 | $22,585 | |
| 5 | ILMN |
Illumina, Inc.
This page
|
117 | $20,572 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
25 | $13,161 | |
| 7 | MEDP |
Medpace Holdings, Inc.
|
22 | $11,650 | |
| 8 | A |
Agilent Technologies, Inc.
|
27 | $3,586 |
All Filings in ILMN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,572 | 117 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,421 | 117 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $19,018 | 145 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $22,128 | 233 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $24,615 | 258 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $36,020 | 454 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $60,668 | 454 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||